Here are relevant reports on : people-screening-systems-market
-
Marine Onboard Communication and Control Systems Market by Type (Communication Systems, Control Systems), Platform (Commercial, Defense), End User (OEM, Aftermarket) and Region - Global Forecast to 2028
The Marine Onboard Communication and Control Systems market is expected to grow from USD 8.6 billion in 2023 to USD 12.3 billion by 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period.The key players Emerson Electric Co. (US), Wartsila (Finland), Kongsberg (Norway), ABB (Switzerland), and Northrop Grumman Corporation (US).
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Automotive Gesture Recognition Systems Market by Component Type (Touch Based Systems, and Touchless Systems), Authentication Type (Hand/Fingerprint/Leg, Face, Vision/iris), Application (Lighting System), and Region - Global Forecast to 2021
The automotive gesture recognition systems (GRS) market is projected to grow at a CAGR of 30.5%, from USD 829.5 Million in 2016 to USD 3144.8 Million by 2021. The rise in consumer preference for application based technologies and increasing awareness about driver safety and regulations in automobile industry have fueled the growth of the automotive gesture recognition systems market. The increase in demand for autonomous and electric vehicles is also a major factor that will contribute to the growth of the automotive GRS market.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Air Quality Control Systems Market by Technology (FGD, Electrostatic Precipitators, NOx Control Systems, Scrubber & Mercury Control Systems), Pollutant Type (Gas, Dust, Multi-Pollutant), Product type, End User & Region - Global Forecast to 2029
The global Air Quality Control Systems Market is projected to reach USD 150.7 billion by 2029, at a CAGR of 7.0% during the forecast period. Some of the major players in the Air Quality Control Systems market are Mitsubishi Heavy Industries (Japan), GE Vernova Inc (US), GEA (Germany), Daikin Industries, Ltd. (Japan) and Donaldson Company, Inc. (US) among others. The major strategies adopted by these players include new product launches, acquisitions, contracts, agreements, partnerships, joint ventures, collaborations, investments, and expansions.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Home Healthcare Market by Product (Therapeutic, Testing, Screening, Monitoring, Mobility Care), Service (Nursing, Infusion Therapy, Rehabilitation, Palliative Care), Indication (Cancer, Diabetes, CVD, Respiratory, Wound Care) - Global Forecast to 2030
The global home healthcare market, valued at US$285.3 billion in 2024, stood at US$309.9 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$473.8 billion by the end of the period. This growth is driven by the rising elderly population, which is more prone to chronic conditions such as hypertension, diabetes, and cardiovascular diseases, increasing the need for ongoing care at home.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Preimplantation Genetic Testing Market by Product & Service (Reagents, Consumables, Instruments, Software), Technology (NGS, PCR, SNP, CGH), Procedure (Screening, Diagnosis), Application (Aneuploidy, HLA Typing), Type of cycle - Global Forecast to 2030
The global preimplantation genetic testing market, valued at US$636.4 million in 2024, stood at US$690.2 million in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2024 to 2030, culminating in a forecasted valuation of US$1,135.0 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Biochips Market by Products & Services (Instruments, Software), Type (DNA Chips, Protein Chips, Lab-on-a-Chip), Application (High-throughput Screening, IVD, POC), Fabrication Technology (Microarrays, Microfluidics), & Region - Global Forecast to 2030
The global biochips market, valued at US$12,907.5 million in 2024, stood at US$14,011.6 million in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2024 to 2030, culminating in a forecasted valuation of US$21,356.4 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
U.S. Cervical Cancer Screening Market by Test Type (PAP, HPV), Kit Type (PAP, HPV), End User (Hospitals, Laboratories, Physicians’ Offices & Clinics) - Global Forecast to 2020
The global cervical cancer screening market was approximately $15 billion in 2014 and is estimated to grow at a CAGR of 7.0% to reach nearly $22 billion by 2020. PAP test is the largest segment of the global cervical cancer screening market. However, HPV/co-test will be the fastest-growing product segment during the forecast period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits, Microplates), Software), Application (Drug Discovery & Development, Toxicology), End User - Global Forecast to 2030
Global high content screening market valued at $1.47B in 2024, reached $1.52B in 2025, and is projected to grow at a robust 7.5% CAGR, hitting $2.19B by 2030. Market growth in the Asia Pacific can be attributed to the increased pharmaceutical and biotechnology investments and the rising demand for personalized medicine.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023
The lung in vitro models market is projected to reach USD 427.4 Million by 2023, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in Cell Culture technologies, and the development of new 3D in vitro models. The major players in the Lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).
- Published: April 2018
- Price: $ 11000
- TOC Available:
-
Carrier Screening Market by Product and Service, Type (Expanded (Customized, Predesigned) Targeted Diseases, Medical condition (Hematologic, Pulmonary), Technology (DNA Sequencing, PCR), End User, Region - Global Forecast to 2028
The global carrier screening market, valued at US$1.8 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 19.7% from 2023 to 2028, culminating in a forecasted valuation of US$5.4 billion by the end of the period. The expansion of this market is majorly due to the development and availability of expanded carrier screening panels that cover a wide range of genetic conditions contribute to the market's growth.
- Published: January 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
